Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression

AIDS Research and Human Retroviruses

Volumn 15, Issue 18, 1999, Pages 1691-1701

  Smith, Stephen M ^a,b   Holland, Bart ^b   Russo, Christine ^a   Dailey, Peter J ^c   Marx, Preston A ^d,e   Connor, Ruth I ^e  

^a ST MICHAEL S MEDICAL CENTER   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c BAYER CORPORATION   (United States)

^d TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ANIMAL MODEL; ARTICLE; DISEASE COURSE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS INFECTION; VIRUS LOAD;

EID: 0032764952     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309739     Document Type: Article

References (37)

1. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579.
2. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
3. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, and Gerstoft J: Longitudinal serum HIV RNA quantification: Correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-173.
4. Palumbo PE, Raskino C, Fiscus S, et al.: Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA 1998;279:756-761.
5. Pedersen CA, Katzenstein T, Nielsen C, Lundgren JD, and Gerstoft J: Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: Relation to CD4 cell count and clinical course of primary infection. J Acquir Immune Defic Syndr Hum Retroviral 1997;16:93-99.
6. Carpenter CC, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society - USA panel. JAMA 1998;280:78-86.
7. Katzenstein DA, Hammer SM, Hughes MD, et al.: The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med 1996;335:1091-1098.
8. O'Brien WA, Hartigan PM, Martin D, et al.: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-431.
9. Gulick RM, Mellors JW, Havlir D, et al.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-739.
10. Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol 1990;8:557-578.
11. King NW, Chalifoux LV, Ringler DJ, et al.: Comparative biology of natural and experimental SIVmac infection in macaque monkeys: A review. J Med Primatol 1990;19:109-181.
12. Fultz PN and Anderson DC: The biology and immunopathology of simian immunodeficiency virus infection. Curr Opin Immunol 1989;2:403-408.
13. Lackner AA: Pathology of simian immunodeficiency virus induced disease. Curr Top Microbiol Immunol 1994;188:35-64.
14. Johnson RP: Macaque models for AIDS vaccine development. Curr Opin Immunol 1996;8:554-560.
15. Marx PA, Spira AI, Gettie A, et al.: Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 1996;2:1084-1089.
16. Hirsch VM, Fuerst TR, Sutter G, et al.: Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 1996;70:3741-3752.
17. Lifson JD, Nowak MA, Goldstein S, et al.: The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J VIrol 1997;71: 9508-9514.
18. Watson A, Ranchalis J, Travis B, et al.: Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival. J Virol 1997;71: 284-290.
19. Staprans SI, Dailey PJ, Rosenthal A, et al.: Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J Virol 1999;73:4829-4839.
20. Ishizaka S, Israel Z, Gettie A, et al.: Induction of mucousal antibody responses by micro-sphere encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model. Vaccine 1999;17:2817-2825.
21. Marx PA, Compans RW, Gettie A, et al.: Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993;260:1323-1327.
22. Letvin NL, Daniel MD, Sehgal PK, et al.: Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985;230:71-73.
23. Nowak MA, Lloyd AL, Vasquez GM, et al.: Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol 1997;71:7518-7525.
24. Kuroda MJ, Schmitz JE, Charini WA, et al.: Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999; 162:5127-5133.
25. Sodora DL, Lee F, Dailey PJ, and Marz PA: A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res Hum Retroviruses 1998;14:171-181.
26. Fujii Y, Mukai R, Mori K, et al.: Efficacy of 6-chloro-2′,3′-dideoxyguanosine (6-Cl-ddG) on rhesus macaque monkeys chronically infected with simian immunodeficiency virus (SIVmac239). J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:313-317.
27. Regier DA and Desrosiers RC. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 1990;6:1221-1231.
28. Lu Y, Pauza CD, Lu X, Montefiori DC, and Miller CJ: Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:6-18.
29. Almond N, Kent K, Cranage M, Rud E, Clarke B, and Stott EJ: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 1995; 345:1342-1344.
30. Clements JE, Montelaro RC, Zink MC, et al.: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 1995;69:2737-2744.
31. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, and Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
32. Lohman BL, McChesney MB, Miller CJ, et al.: A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 1994;68:7021-7029.
33. Marthas ML, Miller CJ, Sutjipto S, et al.: Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol 1992;21:99-107.
34. Norley S, Beer B, Binninger-Schinzel D, Cosma C, and Kurth R: Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology 1996;219: 195-205.
35. Stahl-Hennig C, Dittmer U, Nisslein T, et al.: Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol 1996;77:2969-2981.
36. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, and Desrosiers RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70:3724-3733.
37. Connor RI, Montefiori DC, Binley JM, et al.: Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Virol 1998;72:7501-7509.